CGBio History

History

  • IR52 장영실 기술혁신상 수상
  • 의료기기 CuraVAC FDA 승인
  • (주)시지바이오 창립

2020’s

2023
Selected as a company that achieved revenues of one hundred billion won
Establishment of CGMedTech Corporation in the USA
S-Campus Brazil BGMP Certification
Establishment of NULOOK Medical Aesthetic Clinic
Acquisition of M.Base, a specialist in lifting threads
2022
Selected as Hi-Seoul Business
Obtained authorization for a cell processing facility
Concluded NOVOSIS license outsourcing agreement in North America with Orthofix (USA)
Selected as an Outstanding Enterprise for Compensation for Employee’s Invention
Established CGBIO NEOREGEN Indonesia
2021
Selected as a Great Place to Work by the Korea Chamber of Commerce and Industry
Commendation from the Minister of Health and Welfare as an Innovative Medical Appliance Enterprise
Commendation for Merit in SME Growth and Development
Obtained certification for quality management system from the American Association of Tissue Banks (AATB)
CE certification for HA Filler (GISELLELIGNE, VOM)
2020
Obtained CE certification in Europe for Facetem S, EXCELOS Inject, and CG GEL
Selected as a Global Hidden Champion
Selected as a Great Place to Work in Gyeonggi-do
Selected as a Great Place to Work (Medical Appliance SC)
Selected as an Innovative Medical Appliance Enterprise
Awarded the USD 7 Million Export Tower Award
Selected as a Promising SME in Gyeonggi-do

2010’s

2019
Selected as a Family-friendly Workplace
Awarded the USD 3 Million Export Tower Award
Cerebrovascular stent ‘Alpha Stent’ first authorized in Korea
IR52 Jang Young-sil Award – NOVOSIS
Presidential citation for Gender Equality in Employment
Cosmetic surgery filler ‘GISELLELIGNE’ authorized by CFDA in China
2018
Certified as an Outstanding R&D Center by the Ministry of Science and Technology
2017
Selected as the Next-gen World Class Product by the Ministry of Trade, Industry and Energy (NOVOSIS)
Certified as an Outstanding Enterprise for Compensation for Employee’s Invention
Two certifications for new health technology by the Ministry of Health and Welfare (NET): EGF Endoscopy Gel, NOVOSIS
Biofusion medical appliance (rhBMP-2) ‘NOVOSIS’ first authorized in Korea
2016
New Technology Certification for treatment for Hemorrhagic Gastrointestinal Disease Treatment for Endoscopy using epithelial cell growth factor
Received IR52 Jang Young-Sil Award for Technological Innovation
First approval in Korea of NOVOSIS, a medical device with fusion of bone graft-promoting protein ‘rhBMP-2’ and bone graft material
Selected as an Excellent Technology Research Center from Ministry of Trade, Industry and Energy.
Acquirement of certification for New Health Technology (NET)
2015
Achieved ‘Million Dollar Export Tower’ on Trade Day
Jang Young-Sil Award / Minister of Industry Award / Certified for New Health Technology
2013
CE Certification
Acquired FDA approval for CuraVAC (medical device)
2011
ISO 13485 Granted
2010
Medical equipment manufacturing license register
 Approval of Good Manufacturing Practice Regulations (GMP)

2000’s

2009
Inobiz Accreditation/Certification
2008
Human Tissue FDA Registration / Registration as a venture company
2007
Tissue bank authorization/ establishment of Corporate Research Center
2006
Founding of CGBio